Dermatological manifestations during COVID-19 and histological picture: Description of two clinical cases.
COVID-19
SARS-CoV-2 infection
inflammation markers
rash
skin biopsy
Journal
The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
revised:
02
11
2020
received:
12
08
2020
accepted:
05
11
2020
pubmed:
25
2
2021
medline:
15
5
2021
entrez:
24
2
2021
Statut:
ppublish
Résumé
It is not yet entirely clear what is the relevance of skin symptoms and what clinical implications are related to their appearance in COVID-19 patients. We describe two cases of COVID-19-associated pneumonia, which presented skin manifestations in advanced stage of illness, when nasopharyngeal swabs became negative for SARS-CoV-2. The first case presented erythematous, maculopapular lesions; the second developed petechial, vesicular and blood-encrusted lesions on the limbs. Histopathology documented perivascular lymphocytic infiltrates, with prevalent CD4+ T-cells in both patients. The research of SARS-CoV-2 in tissues with real time RT-PCR was negative. Basal keratinocytes displayed C4d deposits in one case, who developed laboratory signs indicative of a procoagulative condition at the same time as the skin rash. Skin manifestations during SARS-CoV-2 infection seem to be clinically relevant and further studies are necessary to assess if they are linked to systemic complications, lack of viral clearance or cascades of immune responses induced by the virus, even in patients affected by mild pneumonia.
Identifiants
pubmed: 33624293
doi: 10.1111/1346-8138.15714
pmc: PMC8013512
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
651-656Subventions
Organisme : Italian Ministry of Health
Informations de copyright
© 2021 Japanese Dermatological Association.
Références
Br J Dermatol. 2020 Jul;183(1):71-77
pubmed: 32348545
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213
pubmed: 32215952
Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 28;41(0):E006
pubmed: 32220276
Biomed Res Int. 2017;2017:3571861
pubmed: 28894750
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e755-e757
pubmed: 32495368
Transl Res. 2020 Jun;220:1-13
pubmed: 32299776
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e779-e781
pubmed: 32810920
Br J Dermatol. 2020 Aug;183(2):e31
pubmed: 32353170
J Invest Dermatol. 2021 Jan;141(1):206-209.e1
pubmed: 32454066
Am J Dermatopathol. 2020 Aug;42(8):564-570
pubmed: 32701690
EMBO Mol Med. 2020 Aug 7;12(8):e12642
pubmed: 32559343